SCHEMBL1357553

SCHEMBL1357553

Cn1ccc(=O)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5316617 0.73 CYP2D6 (0.41)
SCHEMBL20464253 0.67 SMN1; SMN2 (0.39)
SCHEMBL7472670 0.67
SCHEMBL21331900 0.67
SCHEMBL1043341 0.67
SCHEMBL20499392 0.67
SCHEMBL6972697 0.67
SCHEMBL3187336 0.65
SCHEMBL528762 0.65 NPC1 (0.43)
SCHEMBL35355 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4414037-A2 MORPHINAN DERIVATIVES FOR THE TREATMENT OF OPIOID DELTA RECEPTOR AGONIST-RELATED DISEASES Nippon Chemiphar Co., Ltd. (JP) 2024-08-14 EP claimed
EP-3513792-B9 MORPHINAN DERIVATIVES FOR THE TREATMENT OF OPIOID DELTA RECEPTOR AGONIST-RELATED DISEASES NIPPON CHEMIPHAR CO (JP) 2024-07-10 EP claimed
EP-3513792-B1 MORPHINAN DERIVATIVES FOR THE TREATMENT OF OPIOID DELTA RECEPTOR AGONIST-RELATED DISEASES NIPPON CHEMIPHAR CO (JP) 2024-03-27 EP claimed
US-20230159530-A1 MORPHINAN DERIVATIVE NIPPON CHEMIPHAR CO., LTD. (JP) 2023-05-25 US claimed
EP-1329160-A2 4-ACYLAMINOPYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-07-23 EP claimed
US-20250188074-A1 PTPN11 INHIBITORS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2025-06-12 US disclosed
EP-4539840-A1 KINASE MODULATORS AND METHODS OF USE THEREOF Neuron23, Inc. (US) 2025-04-23 EP disclosed
CN-119730846-A Kinase modulators and methods of use thereof 神经元23公司 2025-03-28 CN disclosed
WO-2025029683-A1 PI3K INHIBITORS COGENT BIOSCIENCES, INC. (US) 2025-02-06 WO disclosed
US-20240374583-A1 USE OF MORPHINAN DERIVATIVES FOR TREATMENT OF OPIOID DELTA RECEPTOR AGONIST-RELATED DISEASE NIPPON CHEMIPHAR CO., LTD (JP) 2024-11-14 US disclosed
US-12109209-B2 Use of morphinan derivatives for treatment of opioid delta receptor agonist-related disease NIPPON CHEMIPHAR CO., LTD. (JP) 2024-10-08 US disclosed
WO-2023244788-A9 KINASE MODULATORS AND METHODS OF USE THEREOF NEURON23, INC. (US) 2024-09-12 WO disclosed
EP-0014503-A1 Process for preparing highly concentrated finely dispersed solid compositions of water insoluble to slightly soluble active compounds dispersible in an aqueous medium, containing little or no dispersing agent Rohner AG Pratteln (CH) 1980-08-20 EP disclosed
US-4203980-A BACTERICIDES, POTENTIATORS HOFFMANN-LA ROCHE INC. (US) 1980-05-20 US disclosed
US-4191758-A BACTERICIDES HOFFMANN-LA ROCHE INC. (US) 1980-03-04 US disclosed
EP-0003212-A1 2.4-Diamino-5-benzylpyrimidines, pharmaceutical compositions containing them and their preparation F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1979-08-08 EP disclosed
US-4076810-A Benzylpyrimidine antibacterial composition HOFFMANN-LA ROCHE INC. (US) 1978-02-28 US disclosed
US-4039543-A SUBSTITUTED BY AMINE, N-RING, AMIDE, CARBAMATE, UREA HOFFMANN-LA ROCHE INC. (US) 1977-08-02 US disclosed
US-4024145-A Benzylpyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 1977-05-17 US disclosed
US-3931181-A BACTERICIDE HOFFMANN-LA ROCHE INC. (US) 1976-01-06 US disclosed